Myriad Genetics | DEF 14A: Definitive information statements
Apr 18 04:37
Myriad Genetics | DEFA14A: Others
Apr 18 04:36
Myriad Genetics | 8-K: Current report
Feb 28 05:14
Myriad Genetics | 8-K: Current report
Jan 16 13:00
Myriad Genetics | 8-K: Current report
Dec 21, 2023 21:30
Myriad Genetics | 8-K: Current report
Nov 14, 2023 05:31
Myriad Genetics | 8-K: Current report
Nov 9, 2023 10:16
Myriad Genetics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Nov 9, 2023 05:01
Myriad Genetics | 8-K: Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth ; Raises 20 23 Revenue Guidance andIntroduces 2024 Revenue Guidance
Nov 7, 2023 05:05
Myriad Genetics | 8-K: Current report
Nov 1, 2023 21:00
Myriad Genetics | 8-K: Current report
Nov 1, 2023 04:34
Myriad Genetics | 8-K: Current report
Oct 11, 2023 21:00
Myriad Genetics | 8-K: Current report
Oct 5, 2023 20:30
Myriad Genetics | 8-K: Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth
Aug 4, 2023 04:05
Myriad Genetics | 8-K: Current report
Jul 6, 2023 20:24
Myriad Genetics | 8-K: Current report
Jun 3, 2023 04:31
Myriad Genetics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jun 2, 2023 04:02
Myriad Genetics | 8-K: Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range
May 4, 2023 04:06
Myriad Genetics | DEFA14A: Others
Apr 13, 2023 04:08
Myriad Genetics | DEF 14A: Definitive proxy statements
Apr 13, 2023 04:08
No Data
No Data